Co-amoxiclav Moxiclav 156.25MG/5ML SUSPENSION

UGX 19,000

Co-amoxiclav is indicated for the treatment of the following infections in adults and children: Acute bacterial sinusitis (adequately diagnosed), Acute otitis media, Acute exacerbations of chronic bronchitis (adequately diagnosed), Community acquired pneumonia, Cystitis, Pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, Bone and joint infections, in particular osteomyelitis